CLOSE
MENU
Chordia Therapeutics Inc.
Investor Relations
Investor Relations
サブ-ナビゲーション
Company
Science/Pipleline
News
現在位置:
Investor Relations
Management Policies
Financial Information
IR Library
Stock Information
IR Calender
IR News
IR FAQ
Disclaimer
Career
Contact
Privacy Policy
Term of use
Sitemap
Investor Relations
Top Message
Financial Highlights
IR News
Oct 15, 2024
Fiscal year ended August 2024 Financial Results Presentation
(1,465KB)
Oct 11, 2024
Non-consolidated Financial Results for the Fiscal Year Ended August 31, 2024 [Japanese GAAP]
(538KB)
Oct 11, 2024
Chordia to Present Results of Phase 1 Clinical Trial of CLK Inhibitor CTX-712 at the 2024 The 86th Annual Meeting of the Japanese Society of Hematolog
(283KB)
Oct 01, 2024
Announcement of Presentation on Phase 1 Clinical Trial of CLK Inhibitor CTX-712 at the 86th Annual Meeting of the Japanese Society of Hematology
(281KB)
Jul 23, 2024
Chordia wins the Minister of Education, Culture, Sports, Science and Technology Award at the Japan Startup Awards 2024.
(610KB)
IR News
IR Calenar
Mid-Jul-24
Announcement of 3Q Financial results of FY2025
Latest Financial Statement
Financial Results
parts_max: 1
Management Policies
Top Message
Discloser Policy
Financial Information
Financial Highlights
Financial Indicators
Cash Flow
IR Library
Financial Results
Stock Information
General Meeting of Shareholders
Stock Price
IR Calender
IR FAQ
Disclaimer
ページの先頭へ
ページの先頭へ
menu
gnavi-box